Open AccessInfliximab does not increase colonic cancer risk associated to murine chronic colitis
Author(s) -
Loris Riccardo Lopetuso,
Valentina Petito,
Tiziano Zinicola,
C. Graziani,
Viviana Gerardi,
Vincenzo Arena,
Maria Emiliana Caristo,
Andrea Poscia,
Giovanni Cammarota,
Alfredo Papa,
Valerio Cufino,
Alessandro Sgambato,
Antonio Gasbarrini,
Franco Scaldaferri
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i44.9727
Subject(s) - medicine , colorectal cancer , infliximab , colitis , gastroenterology , cancer , tumor necrosis factor alpha , inflammation , pathology
To explore the influence of Infliximab (IFX) on cancer progression in a murine model of colonic cancer associated to chronic colitis.